🇺🇸
United States · US · US:59417-104_81d087b6-4cb4-466a-9693-679edeb062e2
Vyvanse
In shortageOrange BookUNIISPLATC N06BA
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTakeda Pharmaceuticals America, Inc.
CountryUS (United States)
ATC codeN06BA
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc115941710410100 CAPSULE in 1 BOTTLE (59417-104-10)
Annotations
UNII (FDA Substance ID)
SJT761GEGS
LISDEXAMFETAMINE DIMESYLATE
RxCUI 673579
Orange Book
N021977
ABABABABABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Lisdexamfetamine Dimesylate Capsule
Raw payload (JSON)
{
"unii": {
"unii": "SJT761GEGS",
"rxcui": "673579",
"inchikey": "CETWSOHVEGTIBR-FORAGAHYSA-N",
"display_name": "LISDEXAMFETAMINE DIMESYLATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"704e4378-ca83-445c-8b45-3cfa51c1ecad": {
"match": "brand_token",
"title": "VYVANSE (LISDEXAMFETAMINE DIMESYLATE) CAPSULE VYVANSE (LISDEXAMFETAMINE DIMESYLATE) TABLET, CHEWABLE [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
"spl_version": "81",
"published_date": "2026-05-06"
}
},
"productid": "59417-104_81d087b6-4cb4-466a-9693-679edeb062e2",
"productndc": "59417-104",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "021977",
"products": [
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "30MG",
"product_no": "001",
"approval_date": "Feb 23, 2007"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "50MG",
"product_no": "002",
"approval_date": "Feb 23, 2007"
},
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "70MG",
"product_no": "003",
"approval_date": "Feb 23, 2007"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "20MG",
"product_no": "004",
"approval_date": "Dec 10, 2007"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "40MG",
"product_no": "005",
"approval_date": "Dec 10, 2007"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "60MG",
"product_no": "006",
"approval_date": "Dec 10, 2007"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "10MG",
"product_no": "007",
"approval_date": "Oct 30, 2014"
}
],
"appl_type": "N"
},
"dea_schedule": "CII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LISDEXAMFETAMINE DIMESYLATE",
"shortage_reason": "Lisdexamfetamine Dimesylate Capsule",
"shortage_status": "current",
"proprietary_name": "Vyvanse",
"active_ingred_unit": "mg/1",
"application_number": "NDA021977",
"marketing_category": "NDA",
"nonproprietary_name": "lisdexamfetamine dimesylate",
"start_marketing_date": "20071210",
"active_numerator_strength": "40"
}Related drugs
Other records sharing ATC code N06BA.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTakeda Pharmaceuticals America, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
Access this data programmatically
Query Vyvanse and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.